– Reuters Citing Nasa, Boeing Statements
Evaxion’s Cancer Immunotherapy Shows Antitumor Effect In Early-Stage Melanoma Study
Evaxion Biotech A/S (NASDAQ:EVAX) has announced results from its Phase 1/2a trial of EVX-01 in metastatic melanoma. Data from the trial…